Cargando…
RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers
BACKGROUND: Runt-related transcription factor 1 (RUNX1) is a vital regulator of mammalian expression. Despite multiple pieces of evidence indicating that dysregulation of RUNX1 is a common phenomenon in human cancers, there is no evidence from pan-cancer analysis. METHODS: We comprehensively investi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088136/ https://www.ncbi.nlm.nih.gov/pubmed/35534796 http://dx.doi.org/10.1186/s12885-022-09632-y |
_version_ | 1784704304200810496 |
---|---|
author | Tuo, Zhouting Zhang, Ying Wang, Xin Dai, Shuxin Liu, Kun Xia, Dian Wang, Jinyou Bi, Liangkuan |
author_facet | Tuo, Zhouting Zhang, Ying Wang, Xin Dai, Shuxin Liu, Kun Xia, Dian Wang, Jinyou Bi, Liangkuan |
author_sort | Tuo, Zhouting |
collection | PubMed |
description | BACKGROUND: Runt-related transcription factor 1 (RUNX1) is a vital regulator of mammalian expression. Despite multiple pieces of evidence indicating that dysregulation of RUNX1 is a common phenomenon in human cancers, there is no evidence from pan-cancer analysis. METHODS: We comprehensively investigated the effect of RUNX1 expression on tumor prognosis across human malignancies by analyzing multiple cancer-related databases, including Gent2, Tumor Immune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), the Human Protein Atlas (HPA), UALCAN, PrognoScan, cBioPortal, STRING, and Metascape. RESULTS: Bioinformatics data indicated that RUNX1 was overexpressed in most of these human malignancies and was significantly associated with the prognosis of patients with cancer. Immunohistochemical results showed that most cancer tissues were moderately positive for granular cytoplasm, and RUNX1 was expressed at a medium level in four types of tumors, including cervical cancer, colorectal cancer, glioma, and renal cancer. RUNX1 expression was positively correlated with infiltrating levels of cancer-associated fibroblasts (CAFs) in 33 different cancers. Moreover, RUNX1 expression may influence patient prognosis by activating oncogenic signaling pathways in human cancers. CONCLUSION: Our findings suggest that RUNX1 expression correlates with patient outcomes and immune infiltrate levels of CAFs in multiple tumors. Additionally, the increased level of RUNX1 was linked to the activation of oncogenic signaling pathways in human cancers, suggesting a potential role of RUNX1 among cancer therapeutic targets. These findings suggest that RUNX1 can function as a potential prognostic biomarker and reflect the levels of immune infiltrates of CAFs in human cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09632-y. |
format | Online Article Text |
id | pubmed-9088136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90881362022-05-11 RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers Tuo, Zhouting Zhang, Ying Wang, Xin Dai, Shuxin Liu, Kun Xia, Dian Wang, Jinyou Bi, Liangkuan BMC Cancer Research BACKGROUND: Runt-related transcription factor 1 (RUNX1) is a vital regulator of mammalian expression. Despite multiple pieces of evidence indicating that dysregulation of RUNX1 is a common phenomenon in human cancers, there is no evidence from pan-cancer analysis. METHODS: We comprehensively investigated the effect of RUNX1 expression on tumor prognosis across human malignancies by analyzing multiple cancer-related databases, including Gent2, Tumor Immune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), the Human Protein Atlas (HPA), UALCAN, PrognoScan, cBioPortal, STRING, and Metascape. RESULTS: Bioinformatics data indicated that RUNX1 was overexpressed in most of these human malignancies and was significantly associated with the prognosis of patients with cancer. Immunohistochemical results showed that most cancer tissues were moderately positive for granular cytoplasm, and RUNX1 was expressed at a medium level in four types of tumors, including cervical cancer, colorectal cancer, glioma, and renal cancer. RUNX1 expression was positively correlated with infiltrating levels of cancer-associated fibroblasts (CAFs) in 33 different cancers. Moreover, RUNX1 expression may influence patient prognosis by activating oncogenic signaling pathways in human cancers. CONCLUSION: Our findings suggest that RUNX1 expression correlates with patient outcomes and immune infiltrate levels of CAFs in multiple tumors. Additionally, the increased level of RUNX1 was linked to the activation of oncogenic signaling pathways in human cancers, suggesting a potential role of RUNX1 among cancer therapeutic targets. These findings suggest that RUNX1 can function as a potential prognostic biomarker and reflect the levels of immune infiltrates of CAFs in human cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09632-y. BioMed Central 2022-05-09 /pmc/articles/PMC9088136/ /pubmed/35534796 http://dx.doi.org/10.1186/s12885-022-09632-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tuo, Zhouting Zhang, Ying Wang, Xin Dai, Shuxin Liu, Kun Xia, Dian Wang, Jinyou Bi, Liangkuan RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
title | RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
title_full | RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
title_fullStr | RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
title_full_unstemmed | RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
title_short | RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
title_sort | runx1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088136/ https://www.ncbi.nlm.nih.gov/pubmed/35534796 http://dx.doi.org/10.1186/s12885-022-09632-y |
work_keys_str_mv | AT tuozhouting runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT zhangying runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT wangxin runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT daishuxin runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT liukun runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT xiadian runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT wangjinyou runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers AT biliangkuan runx1isapromisingprognosticbiomarkerandrelatedtoimmuneinfiltratesofcancerassociatedfibroblastsinhumancancers |